JSC PHARMASYNTEZ-NORD
In 2011, the Pharmasyntez Group of Companies started construction of the Saint Petersburg plant designed specifically for the development and production of up-to-date and effective cytostatic drugs
In 2017, the first stage of the plant was put into operation.
Nowadays, Pharmasyntez-Nord implements an investment project for construction of the second stage of the pharmaceutical plant. The launch is scheduled for 2021.
The project is a part of the state import substitution program.
Mikhail Yuryevich Kvasnikov
Chief Executive Officer of Pharmasyntez-Nord, JSC
Production
- A fully automatic isolated line for the production of aseptic solutions and lyophilized products with the fill-finish technology applied
- A robotized isolated line for filling vials, cartridges, and pre-filled syringes (PFS) with the fill-finish technology applied
- An isolated line by Cos. Mec and B&D (Italy) for coated tablet, capsule, and pellet manufacturing
Pharmasyntez-Nord
Built-up area: 3,970 m²
Clean rooms: 800 m²
Production
Antineoplastic drugs and drugs from the list of the 12 high-cost nosologies program
Dosage forms
Tablets
Capsules
Vials
Prefilled syringes
Cartridges